To examine the relationship between HECTD2 and the KEAP1/NRF2 pathway, we measured the protein expression levels of KEAP1 and NRF2 in lenvatinib‐resistant HCC cell lines following HECTD2 knockdown. Here, KEAP1 is linked to hepatocellular carcinoma.